We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 21

District Court Dismisses Tying and Bundling Claims, Holding that Medical-Surgical Distributor Failed to Show Market Power or Injury to Competition
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • April 12 2016

The federal district court for the District of Kansas recently dismissed claims by a medical products distributor that two of its competitors


Second Circuit applies rule of reason to uphold preliminary injunction preventing manufacturer from removing Alzheimer’s drug from market
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • June 3 2015

In State of New York v. Actavis plc, No. 14-4624-cv (2d Cir. May 22, 2015), the United States Court of Appeals for the Second Circuit addressed "a


Sixth Circuit Court of Appeals adopts below-cost standard for “non-explicit” tying arrangements
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • March 30 2015

The United States Court of Appeals for the Sixth Circuit last week issued a significant opinion limiting the circumstances in which a defendant's


Federal judge preliminarily enjoins Sysco-US foods merger and parties abandon the transaction
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • July 2 2015

In a decision released on June 26, 2015, a federal district court judge in Washington, D.C. ruled in favor of the Federal Trade Commission and issued


FTC announces new Hart-Scott-Rodino and Clayton Act Section 8 thresholds
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 21 2015

The Federal Trade Commission (the "FTC") has revised the jurisdictional and filing fee thresholds of the Hart-Scott-Rodino Antitrust Improvements Act


Supreme Court holds state regulatory board controlled by active market participants is not immune from antitrust liability
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • February 27 2015

When a controlling number of decisionmakers serving on a state regulatory board are active participants in the market or profession being regulated


Fifth Circuit reverses jury verdict for antitrust plaintiffs, finding lack of sufficient evidence to establish a conspiracy
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 23 2015

The United States Court of Appeals for the Fifth Circuit recently reversed a jury verdict of liability under Sections 1 and 2 of the Sherman Act


FTC announces new Hart-Scott-Rodino and Clayton Act Section 8 thresholds
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 27 2012

The Federal Trade Commission (the “FTC”) has revised the jurisdictional and filing fee thresholds of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) and the Premerger Notification Rules (the “Rules”


FTC announces new Hart-Scott-Rodino and Clayton Act Section 8 thresholds
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 25 2011

The Federal Trade Commission (the "FTC") has revised the jurisdictional and filing fee thresholds of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") and the Premerger Notification Rules (the "Rules"


Hart-Scott-Rodino enforcement: executive equity awards can trigger HSR filing obligations
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 6 2012

The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”) requires parties intending to acquire voting securities, assets or certain non-corporate interests to notify the Federal Trade Commission (“FTC”) and the Department of Justice, Antitrust Division (“DOJ”), and to observe certain waiting periods, if the HSR filing thresholds are met